SCI/SCI-E ve Diğer İndekslerde Yurt Dışı Eserleri:1.Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib. Maral S, Bakanay SM, Kucuksahin O, Dilek I.

J Oncol Pharm Pract. 2019 Jul 30:1078155219863469. doi: 10.1177/1078155219863469

2. The rare coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: a case report. Yıldız, A., Şahin, O., Yayar, O., Öztürk, Ç. P., Öztürk, H. BA.Ozturk, Maral S., Okutan H., Albayrak, M. (2018). Transfus Apher Sci. 2018 Jun;57(3):398-400. doi: 10.1016/j.transci.2018.04.023. Epub 2018 Apr 26.

3. Dimethyl Sulfoxide-Induced Tonic Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells. Maral S, Albayrak M, Pala C, Yildiz A, Sahin O, Ozturk HB. Cell Tissue Bank. 2018 Aug 11. doi: 10.1007/s10561-018-9718-x.

4. Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience. Yıldız, A., Öztürk, H. B., Albayrak, M. Pala, Ç., Şahin O., Maral S., & Okutan, H. J Oncol Pharm Pract. 2018 Aug 22:1078155218795323. doi: 10.1177/1078155218795323.

5. Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors. Yıldız A, Albayrak M, Pala Çiğdem, Şahin O, Afacan Öztürk H, Güneş G, Maral S, Okutan H. J Infect Dev Ctries. 2018 12:741-747. doi: 10.3855/jidc.10399.PMID: 31999632

6. Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate. Maral S, Bakanay SM, Yikilmaz AS, Dilek I. J Cancer Res Ther. 2018 Oct-Dec;14(6):1431-1433. doi: 10.4103/0973-1482.192762.

7. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase I Clinical Study to Demonstrate Safety of Ankaferd Blood Stopper Topical Usage In Healthy Volunteers. Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, Goker H, Haznedaroglu IC, Kosar A. UHOD 2012:22(4 );267-274 doi: 10.4999/uhod.10124

8. Acquired hemophilia with thrombosis in a cancer patient: an unusual presentation Maral S, Bakanay SM, Dilek I. Blood Coagul Fibrinolysis. 2018 Jan;29(1):129-130. doi: 10.1097/MBC.0000000000000670. PMID: 29095762.

9. Rare aggressive natural killer cell leukemia presented with leukopenia and disseminated intravascular coagulation—a diagnostic challenge. O Şahin, ÇP Öztürk, HBA Öztürk, S Maral- J Hematopathol 11, 5–7 (2018). https://doi.org/10.1007/s12308-017-0313-z

10. Refractory Thrombotic Thrombocytopenic Purpura in a patient with Kaposi sarcoma. Sahin O, Albayrak M, Yıldız A, Pala Ç, Aktas L, Maral S, Afacan Öztürk HB, Cömert P. Transfus Apher Sci. 2019 Apr;58(2):187-189. doi: 10.1016/j.transci.2019.02.003. Epub 2019 Mar 19.

11. A first time report on the coocurrence of sarcoidosis and ALK(-) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment.Afacan Öztürk HB, Albayrak M, Pala Öztürk Ç, Yıldız A, Maral S, Önder E. J Oncol Pharm Pract. 2019 Mar 25:1078155219837331. doi: 10.1177/1078155219837331

12.CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic Leukemia.Afacan-Öztürk HB, Falay M, Albayrak M, Yıldız A, Öztürk ҪP, Maral S, Özet G. Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180802.

13.Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study. Maral S, Acar M, Balcik OS, Uctepe E, Hatipoglu OF, Akdeniz D, Altun HU, Kosar A, Gunduz M, Gunduz E.Medicine (Baltimore). 2015 Apr;94(16):e732. doi: 10.1097/MD.0000000000000732.

14. CD25 Expression is Associated with Autoimmunity in Patients with CLL .Ozturk Hb, Yıldız A, Albayrak M, Pala C, Maral S, Falay M . UHOD. 2019:29;123-129 doi: 10.4999/uhod.193789

17. The least incompatible crossmatch red blood cell transfusion by biological compatibility test. Maral S, Bakanay SM, Akıncı S, Yıkılmaz AS, Comert P, Dilek I. GJTM.2019:4(2);154-157 DOI: 10.4103/GJTM.GJTM_37_19

18. An acute transverse myelitis attack after autologous stem cell transplantation: A rare case. Cömert P, Albayrak M, Yıldız A, Şahin O, Öztürk ÇP, Maral S, Güneş G, Afacan Öztürk HB, Sağlam B.Transfus Apher Sci. 2019 Jun;58(3):341-343. doi:10.1016/j.transci.2019.05.002. Epub 2019 May 14.

19. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Malkan UY, Albayrak M, Yildiz A, Maral S, Afacan Ozturk HB, Comert P.J Oncol Pharm Pract. 2020 Jun 6:1078155220929750. doi: 10.1177/1078155220929750. Online ahead of print.

20. Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia. Maral S, Albayrak M, Dagdas S, Yıldız A, Yıldırım R, Oz M, Pala C, Afacan Ozturk HB, Bay I, Ozet G, Dilek I.Clin Lymphoma Myeloma Leuk. 2020 Sep;20(9):e616-e621. doi: 10.1016/j.clml.2020.04.005. Epub 2020 Apr 22.PMID: 32418838

21. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase I Clinical Study To Demonstrate Safety of Ankaferd Blood Stopper Topical Usage In Healthy Volunteers: 336 Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, Goker H, Haznedaroglu IC, Kosar A. Int J Lab Hematol 2010;32:126-127.

22. Q fever as a rare cause of hemophagocytic lymphohistiocytosis: Case report. Sağlam B, Albayrak M, Acar A, Yıldız A, Maral S, Tığlıoğlu M, Battal İ, Şahin EN, Kuş A.Transfus Apher Sci. 2020 Aug;59(4):102747. doi: 10.1016/j.transci.2020.102747. Epub 2020 Feb 28.PMID: 32171685

23. Diffuse large B cell lymphoma progression with skin involvement: A case report. Akyol P, Albayrak M, Maral S, Canpolat F, Afacan Öztürk HB, Sağlam B, Tığlıoğlu M.J Tissue Viability. 2020 Aug;29(3):216-217. doi: 10.1016/j.jtv.2020.04.001. Epub 2020 Apr 9.PMID: 32340715

24. Synchronous detection of multiple myeloma and acute myeloid leukemia: A diagnostic and therapeutic challenge. Maral S, Albayrak M, Sahin O, Ozturk HBA, Han U, Falay M. J Oncol Pharm Pract. 2021 Mar;27(2):464-469. doi: 10.1177/1078155220932352. Epub 2020 Jun 17.

25. Primary Splenic Diffuse Large B Cell Lymphoma. Case Report and Literature Review. Öztürk, H.B.A., Albayrak, M., Pala, Ç. Yıldız S, Maral S, Şahin O, Cömert P,Han U. SN Compr. Clin. Med. 2, 2448–2451 (2020). https://doi.org/10.1007/s42399-020-00523-6

26. Transfusion in autoimmune hemolytic anemia: comparison of two different strategies. Maral S., AlbayrakM., YıldızA., ÖztürkH. B. A., Dilek I. (2020). Medical Science and Discovery, 7(8), 589-93. https://doi.org/10.36472/msd.v7i8.404

27. Modified R-IDARAM treatment in central nervous system lymphomas: A single centre experience. Maral S, Albayrak M, Pala C, Ozturk HBA, Yıldız A, Şahin O, Okutan H. Avicenna J Med. 2020: 10( 4): 227-231 DOI: 10.4103/ajm.ajm_59_19

28.Rare Entity in Chronic Myelocytic Leukemia: Coexistence of BCR ABL1 Translocation and JAK2 V617F Mutation. Case Report Sağlam B, Albayrak M, Yıldız A, Akyol P, Pala C,Maral S, Öztürk HBA, Tığlıoğlu M, Şahin O.SN Comprehensive Clinical Medicine (2020) 2:478–480 doi.org/10.1007/s42399-020-00252-w

29. The outcome of COVID-19 in patients with hematological malignancy. Tığlıoğlu P, Albayrak M, Tığlıoğlu M, Öztürk HBA, Aras MR, Sağlam B, Maral S.Memo. 2021 Dec 9:1-7. doi: 10.1007/s12254-021-00775-5.

30.A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.Malkan UY, Albayrak M, Yildiz A, Maral S, Afacan Ozturk HB, Comert P. J Oncol Pharm Pract. 2021 Jan;27(1):250-252. doi: 10.1177/1078155220929750. Epub 2020 Jun 6.

31. Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment. Yılmaz F, Albayrak M, Tığlıoğlu P, Tığlıoğlu M, Sağlam B, Reis Aras M, Maral S, Afacan Öztürk HB. J Oncol Pharm Pract. 2021 Nov 13:10781552211060730. doi: 10.1177/10781552211060730.

32. Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. A Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20.

33. Co-occurence of follicular lymphoma and Langerhans cell histiocytosis with primary parotid gland involvement: a case report. Albayrak A, Yıldız A, Albayrak M, Özhamam EU, Maral S. Hematol Transfus Cell Ther. 2021 Sep 15:S2531-1379(21)00127-9. doi: 10.1016/j.htct.2021.06.015. Epub ahead of print.

34. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case. Afacan Ozturk HB, Albayrak M, Maral S, Reis Aras M, Yilmaz F, Akyol P, Tiglioglu M, Malkan UY. J Oncol Pharm Pract. 2021 Dec;27(8):2027-2029. doi: 10.1177/10781552211007889. Epub 2021 Apr 13.

35.Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies. Civriz Bozdağ S, Cengiz Seval G, Yönal Hindilerden İ, Hindilerden F, Andıç N, Baydar M, Aydın Kaynar L, Toprak SK, Göksoy HS, Balık Aydın B, Demirci U, Can F, Özkocaman V, Gündüz E, Güven ZT, Özkurt ZN, Demircioğlu S, Beksaç M, İnce İ, Yılmaz U, Eroğlu Küçükdiler H, Abishov E, Yavuz B, Ataş Ü, Mutlu YG, Baş V, Özkalemkaş F, Üsküdar Teke H, Gürsoy V, Çelik S, Çiftçiler R, Yağcı M, Topçuoğlu P, Çeneli Ö, Abbasov H, Selim C, Ar MC, Yücel OK, Sadri S, Albayrak C, Demir AM, Güler N, Keklik M, Terzi H, Doğan A, Yegin ZA, Kurt Yüksel M, Sadri S, Yavaşoğlu İ, Beköz HS, Aksu T, Maral S, Erol V, Kaynar L, İlhan O, Bolaman AZ, Sevindik ÖG, Akyay A, Özcan M, Gürman G, Ünal Ş, Yavuz Y, Diz Küçükkaya R, Özsan GH. Turk J Haematol. 2022 Feb 23;39(1):43-54. doi: 10.4274/tjh.galenos.2021.2021.0287. Epub 2021 Sep 15.

36. Castleman Disease: A Multicenter Case Series from Turkey.Gündüz E, Kırkızlar HO, Ümit EG, Karaman Gülsaran S, Özkocaman V, Özkalemkaş F, Candar Ö, Elverdi T, Küçükyurt S, Paydaş S, Ceneli Ö, Karakuş S, Maral S, Ekinci Ö, İpek Y, Kis C, Güven ZT, Akdeniz A, Celkan T, Eroğlu Küçükdiler AH, Akgün Çağlıyan G, Özçelik Şengöz C, Karataş A, Bulduk T, Özcan A, Belen Apak FB, Canbolat A, Kartal İ, Ören H, Töret E, Özdemir GN, Bakanay Öztürk ŞM. Turk J Haematol. 2022 Feb 18. doi: 10.4274/tjh.galenos.2022.2021.0670. Epub ahead of print. PMID: 35176839.

37. A rare case of pulmonary lymphomatoid granulomatosis complicated with venous thrombosis. Maral S, Albayrak M, Ozturk HBA, Incekara F, Yıldız A, Comert P, Albayrak A, Aras MR, Kaya S. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021038. doi: 10.36141/svdld.v38i4.10140. Epub 2022 Jan 13.

38. Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience . Tığlıoğlu P, Albayrak M, Yıldız A, Tığlıoğlu M, Sağlam B, Aras MR, Yılmaz F, Maral S, Öztürk HBA, Malkan UY. J Hematopathol 2022. https://doi.org/10.1007/s12308-022-00488-6

39.The Importance of Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia. Öztürk HBA, Albayrak M, Yıldız A, Maral S, Akyol P, Aras MR, Falay M. UHOD , 2021:31; 199-204 doi: 10.4999/uhod.215209

40.A Rare Entity in Chronic Myelocytic Leukemia: Coexistence of BCR ABL1 Translocation and JAK2 V617F Mutation. Case Report Sağlam B, Albayrak M, Yıldız A, Akyol P, Öztürk ÇP, Maral S, Öztürk HBA, Tığlıoğlu Mt, Şahin O. SN Comprehensive Clinical Medicine (2020) 2:478–480

ULAKBİM ve Diğer İndekslerde Yurt içi Eserleri:

1.Thrombocytosis Associated with Iron Deficiency Anemia; Is It a Masked Myeloproliferative Disorder? Maral S. AMJ 2019:19(2);375 – 380 DOI: 10.17098/amj.570912

2. Thiol – Disulphide Homeostasis in Polycythemia Vera Yıkılmaz AS , Bakanay SM, Akinci S, Maral S, Mustafayev F , Alisik M, Erel O , Dilek I. Dicletıpdergisi 2019:46(2); 315 – 320 doi.org/10.5798/dicletip.574893

3. Erişkin lenfoma hastalarının epidemiyolojik ve sağkalım verileri: tek merkez deneyimi. Yıldız A , Afacan Öztürk H , Albayrak M , Şahin O , Pala Öztürk Ç , Maral S , Sarıbacak Can E , Güneş G , Okutan H . Ortadoğu Tıp Dergisi. 2018; 240-246. doi.org/10.21601/ortadogutipdergisi.395616

4. Are the conventional risk factors still valid for acute myeloid leukemia patients? Yıldız A, Maral S, Albayrak M, Pala Ç , Cömert P, Öztürk HBA, Şahin O, Konuralp Medical Journal, vol. 12, no. 1, pp. 5-11, Mar. 2020, doi:10.18521/ktd.549666

5. Absolute lymphocyte count is a predictor of outcome after splenectomy for immune thrombocytopenia Yıldız A, Albayrak M, Pala Ç, Şahin , Kuş A, Maral S, Cömet P, Öztürk HB A Gulhane Med J 2020;62:103-8 DOI: 10.4274/gulhane.galenos.2019.855

6. Kronik Lenfositik Lösemi Tanılı Olguların Klinik Seyir, Prognostik Özellikler ve Tedavi Cevabı Yönünden Değerlendirilmesi: Tek Merkez Deneyimi Öztürk HBA, Albayrak M, Pala C, Maral S, Yıldız A, Şahin O, Cömert P. Acta Oncol Tur.. 2019; 52(3): 383-387 | DOI: 10.5505/aot.2019.41033

7. Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients Akyol P, Yıldız A, Albayrak M, Öztürk HBA, Maral S , Aras MR, Yılmaz F, Tığlıoğlu M, Sağlam B, Malkan UY. Gulhane Med J 2021;63:117-22DOI: 10.4274/gulhane.galenos.2020.1243

8.Analysis of Demographic and Disease Characteristics of Patients with Chronic Myeloid Leukemia: A Single Centre Retrospective Analysis Tığlıoğlu M, Albayrak M, Yıldız A, Tığlıoğlu P, Sağlam B, Yılmaz F, Malkan UY, Maral S. Acta Oncol Tur.2022; 55(1): 43-51 | DOI: 10.5505/aot.2022.08831

9.Analysis of clinical and demographic characteristics for the differential diagnosis of pseudothrombocytopenia. Yıldız A, Albayrak M, Şahin O, Öztürk Hba, Maral S Acta Oncol Tur.2020; 53(2): 342-48 Doi: 10.5505/aot.2020.92499

10. Saçlı Hücreli Lösemi Tedavisinde Kladribinin Prognoza Etkisi. Maral S, Albayrak M, Öztürk HBA, Yıldız A, Akyol P, Sağlam B, Tığlıoğlu M, Reis AM. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 2020;7(3):131-134

11 A Retrospective Evaluation of Cases with Adult-Onset Langerhans Cell Histiocytosis: A Single-Center Experience of 14 Cases. Öztürk HBA, Albayrak M, Yıldız A, Maral S, Akyol P, Reis AM. Akd Med J 2020;2:277-80. DOI: 10.17954/amj.2020.2448

12. An Independent Risk Factor For Quality of Life In Cancer Patients: Urinary Incontinence Sılay K, Akıncı S, Baştürk A, Ulaş A, Ulusoy N, Maral S, Yalçın B, Dilek İ. Acta medica 2015;4(3):132-36

13. Current Treatment Approaches to Multiple Myeloma with New Agents. Maral S, Albayrak M, Öztürk ÇP. J Clin Exp Invest 2018;9(2):103-112

14. The Prognostic Value of Blood Count Parameters in Patients with Diffuse Large B Cell Lymphoma. Öztürk HBA, Albayrak M, Yıldız A, Maral S, Akyol P, Sağlam B, Tığlıoğlu M. Akd Med J 2021; 7(1):65-70 DOI: 10.17954/amj.2021.2566

15. Azacitidine-Etoposide-Cytosine Arabinoside Combination Therapy In Older Acute Myeloid Leukemias Maral S, Albayrak M, Öztürk ÇP, Yıldız A, Öztürk HBA, Akyol P, Şahin O, Öneç B. Acta Oncol Tur.2020; 53(3):391-95

Yurt İçi ve Yurt Dışı Poster ve Sözlü Sunumlar

1. A Case Of Transfusion Related Acute Lung Injury (TRALI)
Maral S, Bakanay SM, Izdes S, Dilek I XII. Asian Assosiation of Transfusion medicine congress, IX. National transfusion medicine Congress (2016) REF NO:101 Oral Presentation-8

2. Bleomycin-induced pulmonary fibrosıs: experience of two cases in a single centre. S. Maral, M. Albayrak, A. Yıldız, O. Şahin, Ç. Özturk, Ü. Malkan, G. Guneş, E. Sarıbacak Can. VIII. International Eurasian Hematology Congress / Leukemia Research 61S1 (2017),Oral presentation -32

3.A case with multiple solitary plasmacytomas secreting monoclonal protein. Senem maral, Sule Mine Bakanay Aysun Senturk Yıkılmaz İmdat Dilek Internetional leukemia lymphome myeloma congres 2017 refno:65

4.Does Ferritin and vitamin b12 levels have prognostik sigfiance in multiple myeloma patients?Sema akıncı,Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,imdat dile Dilek Internetional leukemia lymphome myeloma congres 2017 ref no:17 ps-08

5.Multiple myeloma in Patients older Than 65 years:a comparative study with younger adult multiple myeloma patients. Sema akıncı,Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,Muhammet Bülent akıncı.imdat dilek Dilek Internetional leukemia lymphome myeloma congres 2017 ref no:14 ps-14

6.The effect of gender on bone lesions in multiple myeloma patients. Aysun Senturk Yıkılmaz,Kamile Sılay,Senem maral ,sule mine bakanay,selin küçükyurt kaya,imdat dile Dilek Internetional leukemia lymphome myeloma congres 2017ref no:65

7. Importance of screening accessory spleen in refractory immune thrombocytopenia. O. Şahin, M. Albayrak, A. Yıldız, S. Maral, C. Pala Ozturk, H. Afacan Ozturk, U. Malkan, G. Guneş, E. Sarıbacak Can. VIII. International Eurasian Hematology Congress / Leukemia Research 61S1 (2017), PP-40

8. Modıfıed r-idaram treatment in central nervous system lymphomas: A single centre experience. S. maral, M. albayrak, C. Pala, H.B. Afacan Ozturk, A. Yıldız, O. Şahin, H. Okutan. 23rd EHA congress, Stockholm, Sweden 2018; 2(s1) 821 (PB1797)

9.Management of adult immune thrombocytopenia: single-center experience of 9 years. O. Şahin, A. Yıldız, M. Albayrak, C. Pala Ozturk, H. Afacan Ozturk, P. Comert, S. Maral. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S26, Oral Presentation-19

10.A first-time report on the co-occurrence of sarcoidosis and ALK(-) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedontin treatment. H. Afacan Ozturk, M. Albayrak, C. Pala Ozturk, A. Yıldız, S. Maral, E. Onder. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S27, OralPresentation-22

11. An unusual coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: Case report' Abdulkerim Yıldız, Osman Şahin, Okan Yayar, Çiğdem Pala Öztürk, Hacer Berna Afacan Öztürk, Senem Maral, Harika Okutan, Murat Albayrak. 11th Annual Congress of the European Association for Haemophilia and Allied Disorders, Madrid, Spain, 2018. P-169

12.Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience. A. Yildiz, H. B. Afacan Öztürk, M. Albayrak, Ç. Pala Öztürk, O. Şahin,S. Maral, H. Okutan. 23rd EHA congress, Stockholm, Sweden 2018; 2(S1) 549 (PS1215)

13. Infections in patients with lymphoma: an analysis of incidence, relationship and risk factors. A. Yildiz, M. Albayrak, Ç. Pala Öztürk, O. Şahin, H.B. Afacan Öztürk, G. Güneş, S. Maral, H. Okutan. 23rd EHA congress, Stockholm, Sweden 2018; 2(S1) 926 (PB2057)

14. A rare presentation of recurrence in acute lymphoblastic leukemia: isolated optic nerve involvement. P. Comert, M. Albayrak, A. Yıldız, C. Pala Ozturk, S. Maral, H. Afacan Ozturk, O. Şahin, B. Sağlam. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S36, PP-07

15. Intermittent bevacizumab therapy experience in hereditary hemorrhagic telangiectasia. O. Sahin, M. Albayrak, A. Yıldız, P. Comert, C. Ozturk, S. Maral, H. Afacan Ozturk. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S39, PP-14

16. An unexpected complication: transverse myelitis after autologous stem cell transplantation. P. Comert, M. Albayrak, A. Yıldız, O. Şahin, C. Pala Ozturk, S. Maral, G. Guneş, H. Afacan Ozturk, B. Sağlam. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S43, PP-26

17. CD81 expression in the differential diagnosis of chronic lymphocytic leukemia. H. Afacan Ozturk, M. Falay, M. Albayrak, A. Yıldız, C. Pala Ozturk, S. Maral, G. Ozet. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S44, PP-29

18. Lactate Dehydrogenase Level Is Associated With A Worse Outcome In Patients With Hairy Cell Leukemia. Senem Maral, Murat Albayrak, Simten Dagdas, Abdulkerim Yıldız, Rahsan Yıldırım, Merih Oz, Cigdem Pala, Berna Ozturk, Ilker Bay, Gulsum Ozet, Imdat Dilek.24th EHA congress, Amsterdam.2019; (PB2013)

19.Refractory thrombotic thrombocytopenic purpura in a patient with Kaposi sarcoma. O. Sahin, M. Albayrak, A. Yildiz, C. Pala Ozturk, L. Aktaş, S. Maral, H. Afacan Ozturk, P. Comert. IXth International Eurasian Hematology Oncology Congress / Leukemia Research 73S1 (2018), S49, PP-44

20. Monoklonal Gamopati ilişkili kriyoglobunemi. Maral S. 28-29 Kasım 2020 7.Akdeniz Sempozyumu (online toplantı) Sözlu sunum

21. HKNH de Aşılama. Maral S. 01-03 Ekim 2020 5.Ulusal Kan ve Kemik İliği Kongresi (online toplantı) Sözlu Sunum

22. Yenı̇ Tanı Multı̇ple Myelom Hastalarında Kemı̇k İlı̇ğı̇ Fı̇brozı̇sı̇nı̇n Prognoz Ve Yanıt Üzerı̇ne Etkı̇sı̇ Var Mıdır? Maral S, Karakus V, Albayrak M, Sevindik OG46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözel sunu-35 Referans Numarası: 116

23. Yenı̇ Tanı Yaşlı Aml Hastalarında Azacı̇tı̇dı̇n Ve Decı̇tabı̇ne İdamesı̇nı̇n Tedavı̇ye Katkısı: Gerçek Yaşam Verı̇sı̇. Karakuş V, Kaya K, Maral S, Gemici AI , Dere Y, Albayrak M, Sevindik OG 46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözel sunu -09 Referans Numarası: 3

24. Post-Polı̇stemı̇ Vera Ve Post-Esansı̇yel Trombosı̇temı̇ Mı̇yelofı̇brozı̇s Gelı̇şı̇mı̇nde Rol Oynayan Predı̇ktı̇f Faktörlerı̇n Analı̇zı̇. Akyol P, Albayrak M, Yıldız A, Tığlıoğlu M, Sağlam B, Aras MR, Yılmaz F, Maral S, Öztürk HBA, Malkan UY 46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) Sözlü Sunum-41 Referans Numarası: 77

25. Dı̇ffüz Büyük B Hücrelı̇ Lenfoma Hastalarında Komorbı̇dı̇te, Nutrı̇syon Ve Performans Durumunun Prognostı̇k Önemı̇. Sağlam S, Albayrak M, Yıldız A, Akyol P, Tığlıoğlu M, Aras MR, Yılmaz F, Maral S, Öztürk HBA. 46. Ulusal Hematoloji Kongresi 2020 (Online toplantı) SS-59 Referans Numarası: 27

Assoc. Prof. Senem MARAL, M.D.